Precision Toxicology to pay $27 million to settle allegations of unnecessary drug testing

Precision Toxicology has agreed to pay $27 million to settle allegations first brought by whistleblowers in three cases, that the company billed the federal government for unnecessary drug tests and paid kickbacks to doctors, the Department of Justice (DOJ) said.

Drug testing has ramped up in recent years, due to the opioid drug epidemic, and with it allegations of fraud and kickbacks.

The cases against Precision, the largest urine drug testing company in the U.S., are three of many complaints made against urine drug testing companies, for unnecessary billing.